Roche subsidiary Genentech expands in manufacturing
March 31, 2015Manufacturing and Production, Sales and Marketing Genentech, Roche, hillsboro, manufacturing, oregon
Californian drugmaker Genentech is planning a $125 million expansion at its Hillsboro manufacturing centre in Oregon. The Roche subsidiary plant …
Immunocore appoints key scientist to board
March 31, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, john bell
UK biotech Immunocore has appointed the Regius Professor of medicine at Oxford University and chairman of the office for the …
Addressing the adherence gap
March 30, 2015Research and Development, Sales and Marketing AstraZeneca, Kings College London, Professor John Weinman, adherence
Poor medication use in patients with long-term health conditions is widely recognised as a global problem that urgently needs to …
Novartis in major oncology drive
March 30, 2015Research and Development, Sales and Marketing Cancer, FDA, MHRA, Novartis, aduro, ceritinib, eams, early access, zykadia
Novartis says it is ‘stepping up its efforts’ in cancer by launching major initiatives to discover new treatments to combat …
J&J and Google partner to build surgical robots
March 30, 2015Medical Communications, Sales and Marketing Biogen, Ethicon, J&J, JJ, Johnson and Johnson, MS, google, robots
The medical device subsidiary of Johnson & Johnson Ethicon is to collaborate with Google to build surgical robots and perform …
GSK and UK government agree meningitis B vaccine deal
March 30, 2015Sales and Marketing AstraZeneca, Bexsero, GSK, Novartis, meningitis v, vaccines
The UK government has agreed a deal with GlaxoSmithKline to provide its meningitis B vaccine Bexsero on the NHS, after …
EMA committee recommends five drugs for approval
March 30, 2015Sales and Marketing Boehringer, CHMP, EMA, Eisai, Europe, Gardasil, Lenvima, Merck, akynzio, jardiance, lilly
Cancer and diabetes treatments are among those given the go ahead in the latest round of approvals by the EMA. …
Funding boost for UK drugs manufacturing
March 30, 2015Manufacturing and Production, Sales and Marketing ABPI, AstraZeneca, BIA, Bristol-Myers Squibb, Britest, Cambridge, Cambridge Crystallographic Data Centre, GlaxoSmithKline, Perceptive Engineering, Pfizer, Process Systems Enterprise, UCB, University of Leeds, amsci, mmip, stfc
The UK government is funding new manufacturing partnerships that will improve design processes and supply chain initiatives to lift the …
Bionor announces three new hires
March 30, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing barbara ruskin, bionor, kamilla rolsted, soren keller
Norwegian biotech Bionor has confirmed that three new members will be joining its executive management team. Dr Barbara Ruskin, senior …
BMS backs rheumatoid arthritis prevention trial
March 27, 2015Sales and Marketing BMS, Bristol-Myers Squibb, Orencia, RA, abatacept, rheumatoid arthritis
Bristol-Myers Squibb is funding a £3 million trial of Orencia as a preventative treatment for rheumatoid arthritis. The study will …
Novo resubmits FDA application for two diabetes drugs
March 27, 2015Sales and Marketing Danish, FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes
Novo Nordisk will re-submit an FDA application for its diabetes drugs Tresiba and Ryzodeg two years after their initial rejection …
Daiichi Sankyo cuts 16% of US staff
March 27, 2015Sales and Marketing Benicar, Daiichi Sankyo, FDA, Ranbaxy, Welchol, ambit, colesevelam, cuts, olmesartan
Daiichi Sankyo is laying off 16% of its staff at its US commercial headquarters as the company braces itself for …
Big pharma teams with government on genomic research
March 27, 2015Research and Development, Sales and Marketing AbbVie, Alexion Pharmaceuticals, AstraZeneca, Biogen, Cameron, Dimension Therapeutics, GSK, Genomic, Genomics england, Helomics, Roche, Takeda, UCB, UK, genomes
Ten firms will partner up with Genomics England to develop new diagnostics and treatments for people with rare diseases and …
BioNano Genomics appoints chief commercial officer
March 27, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioNano Genomics, Terry Salyer
Genome mapping San Diego firm BioNano Genomics has appointed Terry Salyer as its chief commercial officer. Salyer has more than …
Pharma contributes £32 billion to UK economy
March 26, 2015Sales and Marketing Asia, IFPMA, Oceania, UK, economy, freeman, pharma
Pharma generated over half of the UK life sciences industry’s turnover in 2014 according to a report from the Department …
Pharma’s global economic footprint is huge – and growing
March 26, 2015Research and Development, Sales and Marketing Argentina, Asia, IFPMA, Oceania, global, gva, pharma
The pharma industry contributes more than $400 billion to the global economy, according to new research that examines the worldwide …
Sun Pharma completes Ranbaxy acquisition
March 26, 2015Manufacturing and Production, Sales and Marketing Daiichi Sankyo, India, Ranbaxy, Sun Pharma, cci
Sun Pharma has closed its mega merger deal with Ranbaxy and begun the integration of the two businesses. The combined …
£3 million government boost for stem cells
March 26, 2015Research and Development, Sales and Marketing NHS Blood and Transplant, Stem cells, UK, george freeman, government
The UK government will invest £3 million to further improve the provision of stem cells in the UK which will …
Bayer and Regeneron eye drug gains another indication
March 26, 2015Sales and Marketing Bayer, Eylea, FDA, Japan, Lucentis, MRI, Regeneron, aflibercept
Bayer and Regeneron’s Eylea has added to a growing list of indications with its new approval to treat a type …
WHO: New measures needed to reduce high drug costs
March 26, 2015Research and Development, Sales and Marketing Europe, WHO, pricing, transparency, world health organization
New approaches to drug pricing and reimbursement are needed to make sure pharma provides access to new medicines, according to …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
